Study of Tissue, Blood, and Urine Samples From Patients With Advanced Prostate Cancer
NCT00967889 · Status: UNKNOWN · Type: OBSERVATIONAL
Last updated 2013-08-12
Summary
RATIONALE: Studying samples of tissue, blood, and urine from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors find better ways to treat the cancer.
PURPOSE: This research study is looking at tissue, blood, and urine samples from patients with advanced prostate cancer.
Conditions
Interventions
- GENETIC
-
gene expression analysis
- GENETIC
-
protein analysis
- OTHER
-
biologic sample preservation procedure
- OTHER
-
laboratory biomarker analysis
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
David Neil, MD · Cancer Research UK
Eligibility
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-01-31
- Primary Completion
- 2011-06-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
Markers for Early Detection of Prostate Cancer
NCT00340717 ·Status: COMPLETED
-
Decipher Lethal Prostate Cancer Biology - Urine Metabolomics
NCT03237702 ·Status: RECRUITING ·Phase: NA
-
Plasma Analysis for Response Assessment and to DIrect the manaGement of Metastatic Prostate Cancer
NCT04067713 ·Status: ACTIVE_NOT_RECRUITING
-
Study of Blood Samples From Older Patients at High Risk of Developing Prostate Cancer and From Healthy Male Participants
NCT00898274 ·Status: COMPLETED
-
Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing Prostatectomy
NCT01961713 ·Status: RECRUITING
-
Circulating And Intra-Tumoral Chemokines In Patients With Prostate Cancer
NCT02869282 ·Status: WITHDRAWN
-
Investigation of Protein Biomarkers of Prostate Cancer
NCT00323180 ·Status: WITHDRAWN
-
PRostate Cancer Plasma Integrative Multi-modal Evaluation
NCT06981377 ·Status: RECRUITING
-
Circulating Tumor Cells in High-Risk Prostate Cancer Treated With High-dose Radiotherapy and Hormone Therapy
NCT01800058 ·Status: COMPLETED
-
Clinical Study Evaluating Targeted Biopsies and Cytological Imprints in Prostate Cancer
NCT01745718 ·Status: WITHDRAWN ·Phase: NA
-
PRO-STATE:Search for a Protein Profile Corresponding to Fast-developing Lesions and Characterization of Implicated Proteins in Prostate Carcinoma
NCT00427817 ·Status: COMPLETED
-
Genetic Biomarker Discovery for Metastatic Prostate Cancer
NCT03228810 ·Status: COMPLETED
-
Studying Genes, Environment, and Prostate Cancer Risk in Patients With or Without Prostate Cancer
NCT01013129 ·Status: COMPLETED
-
Early Detection of Prostate Cancer
NCT04556916 ·Status: RECRUITING ·Phase: NA
-
Investigation of Urinary Biomarkers for the Detection of Prostate Cancer
NCT05454371 ·Status: WITHDRAWN ·Phase: NA
-
Exploring the Mechanisms and Dynamics of Clonal Evolution Leading to Recurrence in Prostate Cancer
NCT04686188 ·Status: UNKNOWN
-
Metabolomic Study for Localized Prostate Cancer
NCT01968538 ·Status: UNKNOWN
-
Exploiting Risk-Based Risk Stratification in Early Prostate Cancer to Discriminate Progressors From Non-Progressors
NCT04340245 ·Status: ACTIVE_NOT_RECRUITING
-
Study in Predicting Outcome of Patients Undergoing Radiation Therapy for Prostate Cancer
NCT00045331 ·Status: COMPLETED ·Phase: NA
-
Clinico-pathologic Correlative Study of 3T Magnetic Resonance Spectroscopy in the Localization of Prostate Cancer
NCT00310479 ·Status: COMPLETED ·Phase: NA
-
Non-Invasive Biomarkers in Prostate Cancer Disease Management
NCT06144619 ·Status: SUSPENDED
-
Detection of Clinically Significant Prostate Cancer Using a Urinary Multimarker Sensor
NCT04825002 ·Status: UNKNOWN ·Phase: NA
-
Novel MRI Assessment of Prostate Cancer VALIDATE-PRO
NCT05017181 ·Status: UNKNOWN
-
Evaluation of the Technical Feasibility of Testing ct DNA for Homologous Recombination Gene Variants in Metastatic Prostate Cancer.
NCT05415787 ·Status: COMPLETED
-
PROMOTE: Identifying Predictive Markers of Response for Genitourinary Cancer
NCT02735252 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA